Bal Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Strong revenue growth in the latest quarter, reaching ₹94.63 crore, up from ₹92.54 crore in the previous quarter.
Net profit improved significantly to ₹5.53 crore in Q4, indicating effective cost management and operational efficiency.
Operating profit margins have shown resilience, maintaining a positive trend through the quarters, peaking at 3.30% in Q4.

NEGATIVES

Expenses surged in the latest quarter, affecting profitability despite increased revenue.
Material costs remain high, impacting margins, as seen in rising costs from ₹56.83 crore to ₹74.36 crore.
Net profit in Q1 of the following year dropped to ₹0.21 crore, indicating potential challenges ahead.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	70.39	92.54	81.66	94.63	74.36	73.69	73.15	65.87
Expenses	70.11	91.09	80.49	91.33	74.56	72.13	73.09	66.39
Operating Profit	0.27	1.46	1.17	3.30	-0.20	1.57	0.06	-0.51
Other Income	0.16	0.14	0.10	2.45	0.82	-0.20	0.51	0.72
Interest	3.64	3.82	3.66	4.14	4.24	3.65	5.01	4.05
Depreciation	2.53	2.42	2.96	2.16	2.43	2.48	2.69	2.52
Profit Before Tax	0.43	1.60	1.27	5.75	0.62	1.36	0.57	0.21
Tax	0.34	0.63	0.42	0.22	0.36	0.32	0.05	0
Net Profit	0.10	0.97	0.85	5.53	0.26	1.04	0.52	0.21
Eps in Rs	0.06	0.62	0.54	3.73	0.16	0.65	0.33	0.13